|
Post by peppy on Oct 24, 2017 15:25:17 GMT -5
|
|
|
Post by seanismorris on Oct 24, 2017 15:56:40 GMT -5
With no news it looks like the easiest path is down probably to MA(50) or MA(200).
MACD crossover was brutal (this month).
The lack of reaction to the Brazil news suggests it will take better scripts for buyers to reemerge.
The RSI doesn’t suggest we’re oversold, so I don’t expect help from that...
The only thing I see that is interesting is the high volume. Could it be the money raise resulted in people liquidating new shares? I don’t remember any press releases that would suggest the financiers are doing this... but something is going on.
|
|
|
Post by mnholdem on Oct 24, 2017 18:45:21 GMT -5
I suspect that the private buyers that took the latest offering gave been hedging as insurance for their investments. Now that the safety net is in place we'll see a reversal, likely within 1-2 weeks. Good fortune all.
|
|
|
Post by peppy on Oct 24, 2017 18:53:39 GMT -5
I suspect that the private buyers that took the latest offering gave been hedging as insurance for their investments. Now that the safety net is in place we'll see a reversal, likely within 1-2 weeks. Good fortune all. I am hoping this is a flag. look back at may. same price lift. same huge volume increase. and a retest. This one should be set to go.
The tied is turning. (reading the tea leaves)
The trigger was $1.20.
|
|
|
Post by dreamboatcruise on Oct 24, 2017 19:09:43 GMT -5
I suspect that the private buyers that took the latest offering gave been hedging as insurance for their investments. Now that the safety net is in place we'll see a reversal, likely within 1-2 weeks. Good fortune all. So you think we'll be strong going into the quarterly conference call? What are your thoughts on the revenue guidance we were given for 2H2017 and the fact it is looking like it will need to be walked back? Unless there is some offsetting news, I would think that will start to exert downward pressure. Has this fact already been accepted and baked into the price? or am I in a minority in thinking they aren't going to hit the lower end of guidance?
|
|
|
Post by sportsrancho on Oct 24, 2017 19:17:55 GMT -5
I suspect that the private buyers that took the latest offering gave been hedging as insurance for their investments. Now that the safety net is in place we'll see a reversal, likely within 1-2 weeks. Good fortune all. So you think we'll be strong going into the quarterly conference call? What are your thoughts on the revenue guidance we were given for 2H2017 and the fact it is looking like it will need to be walked back? Unless there is some offsetting news, I would think that will start to exert downward pressure. Has this fact already been accepted and baked into the price? or am I in a minority in thinking they aren't going to hit the lower end of guidance? No you sound just like Spencer.
|
|
|
Post by dreamboatcruise on Oct 24, 2017 19:37:51 GMT -5
@sportsrancho... Don't follow him so wouldn't be able to comment on that. What is your "no" about... that you disagree that we'll not hit lower end of revenue guidance or that you agree with that but you don't think it will have any downward pressure on stock price? Or is it simply "No" I shouldn't talk about uncheerful things. I had five question marks and I don't think it would be logically consistent for you to be saying "no" to all five.
Though, I'm suspecting the meaning of invoking "Spencer" (sort of like McCarthy calling someone a communist I'm guessing) is simply that you don't wish to actually comment on what I posted and don't want anyone else to discuss it either.
If this is a reality that is needing to be suppressed by the cheerleaders through attacks, then I'm guessing there is a potential that it will be greeted poorly by the market when it is finally management that must say it and you can't exactly accuse management of being a communist/spencer.
|
|
|
Post by babaoriley on Oct 24, 2017 19:53:51 GMT -5
Really, folks, the price of this stock is so manipulated lately, it's all guesswork in the short term. Scripts need to grow and deals need to be made. No question Mike and team are trying hard.
Big part of scripts is insurance. The long term challenges and goals are clear. The short term price movement, anything but.
|
|
|
Post by rockstarrick on Oct 24, 2017 20:03:34 GMT -5
I suspect that the private buyers that took the latest offering gave been hedging as insurance for their investments. Now that the safety net is in place we'll see a reversal, likely within 1-2 weeks. Good fortune all. It, (today’s volume), definitely had something to do with Deerfield in my opinion, they must’ve hedged their long shares to lock in profits. The rest of 2017 should be really interesting !! Lots of things “could” happen. Good Luck Everybody 😎
|
|
|
Post by sportsrancho on Oct 24, 2017 20:07:25 GMT -5
@sportsrancho... Don't follow him so wouldn't be able to comment on that. What is your "no" about... that you disagree that we'll not hit lower end of revenue guidance or that you agree with that but you don't think it will have any downward pressure on stock price? Or is it simply "No" I shouldn't talk about uncheerful things. I had five question marks and I don't think it would be logically consistent for you to be saying "no" to all five. Though, I'm suspecting the meaning of invoking "Spencer" (sort of like McCarthy calling someone a communist I'm guessing) is simply that you don't wish to actually comment on what I posted and don't want anyone else to discuss it either. If this is a reality that is needing to be suppressed by the cheerleaders through attacks, then I'm guessing there is a potential that it will be greeted poorly by the market when it is finally management that must say it and you can't exactly accuse management of being a communist/spencer. [ Dream, this is what I answered.. “or am I in a minority in thinking they aren't going to hit the lower end of guidance?” So I meant I didn’t think you were in the minority. Spencer in his comments section said almost the exact same thing. I personally have no idea.
|
|
|
Post by mnholdem on Oct 24, 2017 20:15:39 GMT -5
Really, folks, the price of this stock is so manipulated lately, it's all guesswork in the short term. Scripts need to grow and deals need to be made. No question Mike and team are trying hard. Big part of scripts is insurance. The long term challenges and goals are clear. The short term price movement, anything but. A little over two months from today, Medicare will begin coverage for Afrezza. I expect Mike will mention Medicare at the 4Q17 earnings call and that he will significantly raise his 2018 guidance for Afrezza sales at the EOY earnings call in February. Also, Mike recently talked about improved commercial coverage. Most major health plan committed review and enact changes in level coverage on an annual/semi-annual basis. Again, I anticipate that shareholders will see improved coverage for Afrezza effective January 2018.
|
|
|
Post by dreamboatcruise on Oct 24, 2017 20:19:02 GMT -5
@sportsrancho ... Don't follow him so wouldn't be able to comment on that. What is your "no" about... that you disagree that we'll not hit lower end of revenue guidance or that you agree with that but you don't think it will have any downward pressure on stock price? Or is it simply "No" I shouldn't talk about uncheerful things. I had five question marks and I don't think it would be logically consistent for you to be saying "no" to all five. Though, I'm suspecting the meaning of invoking "Spencer" (sort of like McCarthy calling someone a communist I'm guessing) is simply that you don't wish to actually comment on what I posted and don't want anyone else to discuss it either. If this is a reality that is needing to be suppressed by the cheerleaders through attacks, then I'm guessing there is a potential that it will be greeted poorly by the market when it is finally management that must say it and you can't exactly accuse management of being a communist/spencer. [ Dream, this is what I answered.. “or am I in a minority in thinking they aren't going to hit the lower end of guidance?” So I meant I didn’t think you were in the minority. Spencer in his comments section said almost the exact same thing. I personally have no idea. I retract and apologize for jumping to the conclusion you meant that as an attack.
|
|
|
Post by mnholdem on Oct 24, 2017 20:23:36 GMT -5
@sportsrancho ... Don't follow him so wouldn't be able to comment on that. What is your "no" about... that you disagree that we'll not hit lower end of revenue guidance or that you agree with that but you don't think it will have any downward pressure on stock price? Or is it simply "No" I shouldn't talk about uncheerful things. I had five question marks and I don't think it would be logically consistent for you to be saying "no" to all five. Though, I'm suspecting the meaning of invoking "Spencer" (sort of like McCarthy calling someone a communist I'm guessing) is simply that you don't wish to actually comment on what I posted and don't want anyone else to discuss it either. If this is a reality that is needing to be suppressed by the cheerleaders through attacks, then I'm guessing there is a potential that it will be greeted poorly by the market when it is finally management that must say it and you can't exactly accuse management of being a communist/spencer. [ Dream, this is what I answered.. “or am I in a minority in thinking they aren't going to hit the lower end of guidance?” So I meant I didn’t think you were in the minority. Spencer in his comments section said almost the exact same thing. I personally have no idea. Sales will hinge largely upon marketing. A drug company can typically get commercials reviewed by the FDA in about 30 days. MannKind has restructured its agreements with short term debt holders and has raised cash to launch an Afrezza marketing campaign with data from the new label. I chuckled when I recently read a MNKD post concerning a new Afrezza commercial when he wrote: "Come on, Magic Mike...whip it out!"
|
|
|
Post by dreamboatcruise on Oct 24, 2017 20:24:20 GMT -5
Really, folks, the price of this stock is so manipulated lately, it's all guesswork in the short term. Scripts need to grow and deals need to be made. No question Mike and team are trying hard. Big part of scripts is insurance. The long term challenges and goals are clear. The short term price movement, anything but. A little over two months from today, Medicare will begin coverage for Afrezza. I expect Mike will mention Medicare at the 4Q17 earnings call and that he will significantly raise his 2018 guidance for Afrezza sales at the EOY earnings call in February. Also, Mike recently talked about improved commercial coverage. Most major health plan committed review and enact changes in level coverage on an annual/semi-annual basis. Again, I anticipate that shareholders will see improved coverage for Afrezza effective January 2018. Has management given guidance for 2018, or do you mean raise it compared to the 2017 numbers?
|
|
|
Post by mnholdem on Oct 24, 2017 20:25:53 GMT -5
There has only been one number provided for guidance by MannKind: 2H17 sales.
|
|